Terns Pharmaceuticals (TERN) Earnings Date & Reports
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TERN is expected to report earnings to rise 13.46% to -29 cents per share on August 11
Q2'25
Est.
$-0.29
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.04
Q2'24
Beat
by $0.03
The last earnings report on May 09 showed earnings per share of -25 cents, beating the estimate of -30 cents. With 681.80K shares outstanding, the current market capitalization sits at 275.11M.